{"lastClose": 4.789999961853027, "len": 949, "date": "2023-01-09", "alpha_1": -0.6929746016662945, "beta_1": 0.8994388107357288, "drawup_1": 0.7155424508464454, "natr_1": 19.0106529340558, "sup_1": -1.0549756414853508, "res_1": 0.8775226328419554, "bullPattern_1": [], "bearPattern_1": ["SPINNINGTOP"], "rsi_1": 44.186043932735515, "adx_1": 11.005793166714854, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.6703965549295701, "stratHoldAlpha_1": 250.44209559770525, "stratHoldDrawdown_1": -0.7291216883331662, "alpha_3mo": -0.33980865351885137, "beta_3mo": 0.36769955429341566, "drawup_3mo": 0.7155424508464454, "natr_3mo": 19.0106529340558, "sup_3mo": -0.06958945614481833, "res_3mo": 0.07272095230453708, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 44.943821629364734, "adx_3mo": 15.94483834437163, "drawdown_3mo": -0.7223126905552768, "stratHoldSharpe_3mo": -1.0989700584887128, "stratHoldAlpha_3mo": 249.3777275406138, "stratHoldDrawdown_3mo": -0.6500814214997492, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 393102604, "IPO Year": 2019.0, "Name": "NGM Biopharmaceuticals Inc.", "Country": "United States", "alpha%_1": 0.03592573613430175, "beta%_1": 0.4456106510024541, "drawup%_1": 0.7602686732671997, "natr%_1": 0.9999999981896819, "drawdown%_1": 0.020885961833049842, "stratHoldSharpe%_1": 0.2291644493132391, "stratHoldAlpha%_1": 0.03883748864572504, "stratHoldDrawdown%_1": 0.022727712358541527, "alpha%_3mo": 0.22051300281831776, "beta%_3mo": 0.15231150109181923, "drawup%_3mo": 0.9990674712057587, "natr%_3mo": 0.999999997238536, "drawdown%_3mo": 8.302265501850368e-08, "stratHoldSharpe%_3mo": 0.09064001653379128, "stratHoldAlpha%_3mo": 0.0007366781307858192, "stratHoldDrawdown%_3mo": 1.3266833234432722e-07}